Preview Shoulder

K240172

Genesis Software Innovations · cleared 2024-04-04 · product code QIH · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.4)
The Preview Shoulder, a 3D total shoulder arthroplasty (TSA) surgical planning software, is a standalone software application which assists the surgeon in planning reverse and anatomic shoulder arthroplasty.
AlgorithmPost-processing algorithm is added to further refine the 3D mesh quality. Algorithm is added to calculate humerus-side features used for implant selection, placement, and pre-surgical planning.
source quote (p.7)
Post-processing algorithm is added to further refine the 3D mesh quality. Algorithm is added to calculate humerus-side features used for implant selection, placement, and pre-surgical planning.
Adaptive (vs locked)FDA source did not state this
PCCPNo
Cybersecurity addressedYes
source quote (p.4)
Preview Shoulder is a secure software application used by qualified or trained surgeons and is accessed by authorized users.

Validation studies (2)

Standalone

sample size not stated

endpoints: assess the safety and effectiveness of the device; demonstrate the processing of patient images to produce accurate and repeatable 3D reconstructed bones and surgical coordinates provided to the surgeon

Bench

sample size not stated

endpoints: measurement capabilities of the Preview Shoulder were validated to be significantly equivalent to a benchmark tool with CT rendering measurement capabilities, Osirix MD (K101342)

Reported performance (0 observations)

FDA source did not state a quantitative performance metric — non-reporting is itself the signal.

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
3
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K240172